Ace2 Spike Protein
Mouse Monoclonal Anti-SARS Spike Protein IgG |
|||
AB-15710 | Alpha Diagnostics | 20 ug | EUR 489.6 |
Human IgG antibody Laboratories manufactures the ace2 spike protein reagents distributed by Genprice. The Ace2 Spike Protein reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike Protein. Other Ace2 products are available in stock. Specificity: Ace2 Category: Spike Group: Protein
True north Cryobox 5mLBlue |
||
Scientific Laboratory Supplies | PK10 | EUR 153.6 |
True north Cryobox 15mLNatural |
||
Scientific Laboratory Supplies | PK10 | EUR 212.4 |
True north Cryobox 15mLBlue |
||
Scientific Laboratory Supplies | PK10 | EUR 212.4 |
True north Cryobox 50mLNatural |
||
Scientific Laboratory Supplies | PK10 | EUR 210 |
True north Cryobox 50mLBlue |
||
Scientific Laboratory Supplies | PK10 | EUR 210 |
True north Cryobox1.5/2mLNatural |
||
Scientific Laboratory Supplies | PK10 | EUR 162 |
True north Cryobox1.5/2.0mLGreen |
||
Scientific Laboratory Supplies | PK10 | EUR 162 |
SARS-CoV-1 Spike Trimer (S1+S2):ACE2 Inhibitor Screening Colorimetric Assay Kit |
|||
78012 | BPS Bioscience | 96 rxns. | EUR 765 |
Description: Severe acute respiratory syndrome (SARS) is a viral respiratory illness caused by a corona virus called SARS-CoV-1. It was first reported in February 2013 in Asia and the epidemic affected ~ 26 countries and resulted in more than 8000 deaths. Like SARS-CoV-2, SARS-CoV-1 Spike protein recognizes and attaches to the Angiotensin-Converting Enzyme 2 (ACE2) receptor found on the surface of type I and II pneumocytes, endothelial cells, and ciliated bronchial epithelial cells. Drugs targeting the interaction between the Spike protein of SARS-CoV-1 and ACE2 may offer some protection against the viral infection. The SARS-CoV-1 Spike Trimer (S1+S2):ACE2 Inhibitor Screening Assay Kit includes the SARS-CoV-1 Spike protein in its native trimeric conformation to provide a more physiologically relevant screen for inhibitors as well as a compatible platform to investigate the specificity of SARS-CoV-2:ACE2 inhibitors._x000D_ The key to this kit is that the SARS-CoV-1 Spike Trimer (S1+S2) protein provides a more biologically relevant model than monomeric Spike RBD protein for the investigation of SARS-CoV-1/host cell interaction. Only a few simple steps on a microtiter plate are required for the assay. First, SARS-CoV-1 Spike Trimer (S1+S2) is coated on a 96-well plate. Next, Biotin-ACE2 is incubated with SARS-CoV-1 Spike Trimer (S1+S2) on the plate. Finally, the plate is treated with Streptavidin-HRP followed by addition of a colorimetric HRP substrate to produce color, which then can be quenched and measured using a UV/Vis microplate reader. |
SARS-CoV spike protein Antibody |
|||
abx023139-100ug | Abbexa | 100 ug | EUR 1028.4 |
SARS-CoV spike protein Antibody |
|||
abx023143-100ug | Abbexa | 100 ug | EUR 1028.4 |
Spike S1 (B.1.1.7 Variant) (SARS-CoV-2): ACE2 Inhibitor Screening Colorimetric Assay Kit |
|||
78155 | BPS Bioscience | 96 rxns. | EUR 995 |
Description: The Spike S1 (B.1.1.7 Variant) (SARS-CoV-2):ACE2 Inhibitor Screening Colorimetric Assay Kit is designed for screening and profiling inhibitors of the interaction of ACE2 with the B.1.1.7 variant of the SARS-CoV-2 Spike S1 protein. The key to this kit is the high sensitivity of detection of ACE2-Biotin protein by Streptavidin-HRP. Only a few simple steps on a microtiter plate are required for the assay. First, Spike S1 B.1.1.7 protein is coated on a 96-well transparent plate. Next, ACE2-Biotin is incubated with Spike S1 variant on the plate. Finally, the plate is treated with streptavidin-HRP followed by addition of an HRP substrate to produce color, which can then be measured using a UV/Vis spectrophotometer microplate reader. |
Spike S1 (B.1.1.7 Variant) (SARS-CoV-2): ACE2 Inhibitor Screening Chemiluminescence Assay Kit |
|||
78154 | BPS Bioscience | 96 rxns. | EUR 995 |
Description: The Spike S1 (B.1.1.7 Variant) (SARS-CoV-2): ACE2 Inhibitor Screening Chemiluminescence Assay Kit is designed for screening and profiling inhibitors of the interaction of ACE2 with the B.1.1.7 Variant of the SARS-CoV-2 Spike S1 protein. The key to this kit is the high sensitivity of detection of ACE2-Biotin protein by Streptavidin-HRP. Only a few simple steps on a microtiter plate are required for the assay. First, Spike S1 B.1.1.7 protein is coated on a 96-well transparent plate. Next, ACE2-Biotin is incubated with Spike S1 variant on the plate. Finally, the plate is treated with streptavidin-HRP followed by addition of an HRP substrate to produce chemiluminescence, which can then be measured using a luminometer or microplate reader capable of reding chemiluminescence. |
Recombinant SARS Spike gp C Protein |
|||
VAng-Lsx0072-inquire | Creative Biolabs | inquire | Ask for price |
Description: SARS Spike glycoprotein C, recombinant protein from E. coli. |
Spike S1 RBD (B.1.351 Variant) (SARS-CoV-2): ACE2 Inhibitor Screening Colorimetric Assay Kit |
|||
78152 | BPS Bioscience | 96 rxns. | EUR 995 |
Description: The Spike S1 RBD-B.1.351 (SARS-CoV-2): ACE2 Inhibitor Screening Colorimetric Assay Kit is designed for screening and profiling inhibitors of the interaction of ACE2 with the RBD region of the B.1.351 Variant of the SARS-CoV-2 Spike S1 protein. |
Anti-MERSC-CoV Spike Protein antibody |
|||
STJ140102 | St John's Laboratory | 150 µg | EUR 277.2 |
Description: Goat polyclonal to Spike protein of Middle East respiratory Syndrome coronavirus. Coronaviruses access host cells by membrane fusion, a process mediated by specific fusion or “spike” proteins on the virion, often activated by cellular proteases. |
Spike RBD (B.1.1.7 Variant) (N501Y) (SARS-CoV-2): ACE2 Inhibitor Screening Colorimetric Assay Kit |
|||
78133 | BPS Bioscience | 96 rxns. | EUR 995 |
Description: The Spike RBD (SARS-CoV-2) UK variant (N501Y):ACE2 Inhibitor Screening Colorimetric Assay Kit is designed for screening and profiling inhibitors of the interaction of ACE2 with the UK variant (N501Y) of the SARS-CoV-2 Spike RBD protein. The key to this kit is the high sensitivity of detection of ACE2-Biotin protein by Streptavidin-HRP. Only a few simple steps on a microtiter plate are required for the assay. First, Spike RBD protein UK variant is coated on a 96-well transparent plate. Next, ACE2-Biotin is incubated with Spike RBD UK variant on the plate. Finally, the plate is treated with streptavidin-HRP followed by addition of an HRP substrate to produce color, which can then be measured using a UV/Vis spectrophotometer microplate reader. |
Spike S1 RBD (B.1.351 Variant) (SARS-CoV-2): ACE2 Inhibitor Screening Chemiluminescence Assay Kit |
|||
78151 | BPS Bioscience | 96 rxns. | EUR 995 |
Description: The Spike S1 RBD-B.1.351 (SARS-CoV-2): ACE2 Inhibitor Screening Chemiluminescence Assay Kit is designed for screening and profiling inhibitors of the interaction of ACE2 with the RBD region of the B.1.351 variant of the SARS-CoV-2 Spike S1 protein. |
MERS Spike S1 Recombinant protein |
|||
39-102 | ProSci | 0.1 mg | EUR 556.8 |
Description: Since April 2012, cases of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) have been identified in the following countries: Saudi Arabia, Qatar, Jordan, the United Arab Emirates, Oman, Kuwait, Yemen, Lebanon, Iran, Algeria, the United Kingdom, France, Italy, Greece, Germany, the Netherlands, Austria, Tunisia, Egypt, Malaysia, Turkey and the United States of America. Coronaviruses are the cause of the common cold, SARS (severe acute respiratory syndrome) and other severe illnesses with high mortality rates, all are classified into coronavirus family. MERS-CoV is a new type of SARS found in the coronavirus family causing severe pneumonia with sudden and serious respiratory illness with high mortality rates as well. Since January 27th 2015, the WHO has reported 956 human cases, including 351 deaths. More cases of the new coronavirus strain are expected. Like in other coronaviruses, large surface spike glycoprotein is a central structural protein of this virus; it is located above the virion surface to bind and enter into the target cell. Spike protein has 2 domains- S1 and S2. The S1 domain is responsible for cellular tropism and interaction with target cell, while the S2 domain is responsible for membrane fusion. The C-terminal of S1 domain contains a receptor binding domain, and is also a potential target for vaccine development and an antigen for diagnosis. |
Spike RBD (B.1.1.7 Variant) (N501Y) (SARS-CoV-2): ACE2 Inhibitor Screening Chemiluminescence Assay Kit |
|||
78140 | BPS Bioscience | 96 rxns. | EUR 995 |
Description: The Spike RBD (SARS-CoV-2) UK variant (N501Y):ACE2 Inhibitor Screening Chemiluminescence Assay Kit is designed for screening and profiling inhibitors of the interaction of ACE2 with the UK variant (N501Y) of the SARS-CoV-2 Spike RBD protein. The key to this kit is the high sensitivity of detection of ACE2-Biotin protein by Streptavidin-HRP. Only a few simple steps on a microtiter plate are required for the assay. First, Spike RBD protein UK variant is coated on a 96-well transparent plate. Next, ACE2-Biotin is incubated with Spike RBD UK variant on the plate. Finally, the plate is treated with streptavidin-HRP followed by addition of an HRP substrate to produce chemiluminescence, which can then be measured using a luminometer or microplate reader capable of reading chemiluminescence. |
SARS Spike RBD Recombinant Protein |
|||
10-211 | ProSci | 0.1 mg | EUR 651.3 |
Description: The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensinconverting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity. |
MERS-CoV Spike protein (aa 383-502) [Fc] |
|||
DAG-H10297 | Creative Diagnostics | 20µg | EUR 868.8 |
MERS-CoV Spike protein (aa 367-606) [Fc] |
|||
DAG-H10302 | Creative Diagnostics | 20µg | EUR 868.8 |
MERS-CoV Spike protein (aa 1-1297) [His] |
|||
DAG-H10300 | Creative Diagnostics | 20µg | EUR 868.8 |
MERS-CoV Spike Protein (aa 367-606) [His] |
|||
DAGB201 | Creative Diagnostics | 20 µg | EUR 868.8 |